205 related articles for article (PubMed ID: 7700267)
21. Serogroup F strains of Clostridium difficile produce toxin B but not toxin A.
Depitre C; Delmee M; Avesani V; L'Haridon R; Roels A; Popoff M; Corthier G
J Med Microbiol; 1993 Jun; 38(6):434-41. PubMed ID: 8510136
[TBL] [Abstract][Full Text] [Related]
22. Transcriptional analysis of the toxigenic element of Clostridium difficile.
Hammond GA; Lyerly DM; Johnson JL
Microb Pathog; 1997 Mar; 22(3):143-54. PubMed ID: 9075217
[TBL] [Abstract][Full Text] [Related]
23. Diagnosis and monitoring of Clostridium difficile infections with the polymerase chain reaction.
Kuhl SJ; Tang YJ; Navarro L; Gumerlock PH; Silva J
Clin Infect Dis; 1993 Jun; 16 Suppl 4():S234-8. PubMed ID: 7686782
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of biosite triage Clostridium difficile panel for rapid detection of Clostridium difficile in stool samples.
Landry ML; Topal J; Ferguson D; Giudetti D; Tang Y
J Clin Microbiol; 2001 May; 39(5):1855-8. PubMed ID: 11326003
[TBL] [Abstract][Full Text] [Related]
25. Performance of TechLab C. DIFF QUIK CHEK and TechLab C. DIFFICILE TOX A/B II for the detection of Clostridium difficile in stool samples.
Reyes RC; John MA; Ayotte DL; Covacich A; Milburn S; Hussain Z
Diagn Microbiol Infect Dis; 2007 Sep; 59(1):33-7. PubMed ID: 17662566
[TBL] [Abstract][Full Text] [Related]
26. [Investigation of the presence of Clostridium difficile in antibiotic associated diarrhea patients by culture and toxin detection methods].
Altindiş M; Usluer S; Ciftçi H; Tunç N; Cetinkaya Z; Aktepe OC
Mikrobiyol Bul; 2007 Jan; 41(1):29-37. PubMed ID: 17427550
[TBL] [Abstract][Full Text] [Related]
27. Characterisation of Clostridium difficile strains by polymerase chain reaction with toxin A- and B-specific primers.
Wren BW; Heard SR; al-Saleh AI; Tabaqchali S
J Med Microbiol; 1993 Feb; 38(2):109-13. PubMed ID: 8429535
[TBL] [Abstract][Full Text] [Related]
28. Preliminary molecular analysis of Clostridium difficile isolates from healthy horses in northern Italy.
Ossiprandi MC; Buttrini M; Bottarelli E; Zerbini L
Comp Immunol Microbiol Infect Dis; 2010 Dec; 33(6):e25-9. PubMed ID: 20004974
[TBL] [Abstract][Full Text] [Related]
29. Comparison of antigen and two molecular methods for the detection of Clostridium difficile toxins.
Ylisiurua P; Koskela M; Vainio O; Tuokko H
Scand J Infect Dis; 2013 Jan; 45(1):19-25. PubMed ID: 22998479
[TBL] [Abstract][Full Text] [Related]
30. Clostridium difficile in adult patients with nosocomial diarrhea in a Costa Rican hospital.
Zumbado-Salas R; Gamboa-Coronado Mdel M; Rodríguez-Cavallini E; Chaves-Olarte E
Am J Trop Med Hyg; 2008 Aug; 79(2):164-5. PubMed ID: 18689617
[TBL] [Abstract][Full Text] [Related]
31. Analysis of the pathogenicity locus in Clostridium difficile strains.
Cohen SH; Tang YJ; Silva J
J Infect Dis; 2000 Feb; 181(2):659-63. PubMed ID: 10669352
[TBL] [Abstract][Full Text] [Related]
32. Prevalence of Clostridium difficile toxins A and B and Clostridium perfringens enterotoxin A in stool samples of patients with antibiotic-associated diarrhea.
Heimesaat MM; Granzow K; Leidinger H; Liesenfeld O
Infection; 2005 Oct; 33(5-6):340-4. PubMed ID: 16258864
[TBL] [Abstract][Full Text] [Related]
33. Molecular analysis of Clostridium difficile isolates recovered from horses with diarrhea.
Arroyo LG; Staempfli H; Weese JS
Vet Microbiol; 2007 Feb; 120(1-2):179-83. PubMed ID: 17112686
[TBL] [Abstract][Full Text] [Related]
34. Detection of toxigenic Clostridium difficile in stool specimens by the polymerase chain reaction.
Kato N; Ou CY; Kato H; Bartley SL; Luo CC; Killgore GE; Ueno K
J Infect Dis; 1993 Feb; 167(2):455-8. PubMed ID: 8421180
[TBL] [Abstract][Full Text] [Related]
35. Polymerase chain reaction test for Clostridium difficile toxin B gene reveals similar prevalence rates in children with and without inflammatory bowel disease.
Lamousé-Smith ES; Weber S; Rossi RF; Neinstedt LJ; Mosammaparast N; Sandora TJ; McAdam AJ; Bousvaros A
J Pediatr Gastroenterol Nutr; 2013 Sep; 57(3):293-7. PubMed ID: 23698022
[TBL] [Abstract][Full Text] [Related]
36. Identification of toxin A-negative, toxin B-positive Clostridium difficile by PCR.
Kato H; Kato N; Watanabe K; Iwai N; Nakamura H; Yamamoto T; Suzuki K; Kim SM; Chong Y; Wasito EB
J Clin Microbiol; 1998 Aug; 36(8):2178-82. PubMed ID: 9665986
[TBL] [Abstract][Full Text] [Related]
37. Detection of Clostridium difficile enterotoxin gene in clinical specimens by the polymerase chain reaction.
Boondeekhun HS; Gurtler V; Odd ML; Wilson VA; Mayall BC
J Med Microbiol; 1993 May; 38(5):384-7. PubMed ID: 8487296
[TBL] [Abstract][Full Text] [Related]
38. Laboratory diagnosis of toxigenic Clostridium difficile by polymerase chain reaction: presence of toxin genes and their stable expression in toxigenic isolates from Japanese individuals.
Karasawa T; Nojiri T; Hayashi Y; Maegawa T; Yamakawa K; Wang XM; Nakamura S
J Gastroenterol; 1999 Feb; 34(1):41-5. PubMed ID: 10204609
[TBL] [Abstract][Full Text] [Related]
39. Real-time PCR and typing of Clostridium difficile isolates colonizing mare-foal pairs.
Magdesian KG; Leutenegger CM
Vet J; 2011 Oct; 190(1):119-23. PubMed ID: 21035363
[TBL] [Abstract][Full Text] [Related]
40. Reevaluation of the Premier Clostridium difficile toxin A and B immunoassay with comparison to glutamate dehydrogenase common antigen testing evaluating Bartels cytotoxin and Prodesse ProGastro Cd polymerase chain reaction as confirmatory procedures.
Doing KM; Hintz MS; Keefe C; Horne S; LeVasseur S; Kulikowski ML
Diagn Microbiol Infect Dis; 2010 Feb; 66(2):129-34. PubMed ID: 20117349
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
